Literature DB >> 33822003

Cation leak underlies neuronal excitability in an HCN1 developmental and epileptic encephalopathy.

Lauren E Bleakley1, Chaseley E McKenzie1, Ming S Soh1, Ian C Forster1, Paulo Pinares-Garcia1, Alicia Sedo1, Anirudh Kathirvel1, Leonid Churilov1,2, Nikola Jancovski1, Snezana Maljevic1, Samuel F Berkovic3, Ingrid E Scheffer1,3,4, Steven Petrou1, Bina Santoro5, Christopher A Reid1,3.   

Abstract

Pathogenic variants in HCN1 are associated with developmental and epileptic encephalopathies. The recurrent de novo HCN1 M305L pathogenic variant is associated with severe developmental impairment and drug-resistant epilepsy. We engineered the homologue Hcn1 M294L heterozygous knock-in (Hcn1M294L) mouse to explore the disease mechanism underlying an HCN1 developmental and epileptic encephalopathy. The Hcn1M294L mouse recapitulated the phenotypic features of patients with the HCN1 M305L variant, including spontaneous seizures and a learning deficit. Active epileptiform spiking on the electrocorticogram and morphological markers typical of rodent seizure models were observed in the Hcn1M294L mouse. Lamotrigine exacerbated seizures and increased spiking, whereas sodium valproate reduced spiking, mirroring drug responses reported in a patient with this variant. Functional analysis in Xenopus laevis oocytes and layer V somatosensory cortical pyramidal neurons in ex vivo tissue revealed a loss of voltage dependence for the disease variant resulting in a constitutively open channel that allowed for cation 'leak' at depolarized membrane potentials. Consequently, Hcn1M294L layer V somatosensory cortical pyramidal neurons were significantly depolarized at rest. These neurons adapted through a depolarizing shift in action potential threshold. Despite this compensation, layer V somatosensory cortical pyramidal neurons fired action potentials more readily from rest. A similar depolarized resting potential and left-shift in rheobase was observed for CA1 hippocampal pyramidal neurons. The Hcn1M294L mouse provides insight into the pathological mechanisms underlying hyperexcitability in HCN1 developmental and epileptic encephalopathy, as well as being a preclinical model with strong construct and face validity, on which potential treatments can be tested.
© The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  HCN channels; developmental and epileptic encephalopathy; epilepsy; genetic mouse model; ion channel

Mesh:

Substances:

Year:  2021        PMID: 33822003      PMCID: PMC8370418          DOI: 10.1093/brain/awab145

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   15.255


  4 in total

1.  Seizures, behavioral deficits, and adverse drug responses in two new genetic mouse models of HCN1 epileptic encephalopathy.

Authors:  Andrea Merseburg; Jacquelin Kasemir; Eric W Buss; Felix Leroy; Tobias Bock; Alessandro Porro; Anastasia Barnett; Simon E Tröder; Birgit Engeland; Malte Stockebrand; Anna Moroni; Steven A Siegelbaum; Dirk Isbrandt; Bina Santoro
Journal:  Elife       Date:  2022-08-16       Impact factor: 8.713

2.  Novel HCN1 Mutations Associated With Epilepsy and Impacts on Neuronal Excitability.

Authors:  Changning Xie; Fangyun Liu; Hailan He; Fang He; Leilei Mao; Xiaole Wang; Fei Yin; Jing Peng
Journal:  Front Mol Neurosci       Date:  2022-06-30       Impact factor: 6.261

3.  The Contribution of HCN Channelopathies in Different Epileptic Syndromes, Mechanisms, Modulators, and Potential Treatment Targets: A Systematic Review.

Authors:  Miriam Kessi; Jing Peng; Haolin Duan; Hailan He; Baiyu Chen; Juan Xiong; Ying Wang; Lifen Yang; Guoli Wang; Karlmax Kiprotich; Olumuyiwa A Bamgbade; Fang He; Fei Yin
Journal:  Front Mol Neurosci       Date:  2022-05-19       Impact factor: 6.261

4.  Impaired Color Recognition in HCN1 Epilepsy: A Single Case Report.

Authors:  Chaseley E Mckenzie; Chen-Jui Ho; Ian C Forster; Ming S Soh; A Marie Phillips; Ying-Chao Chang; Ingrid E Scheffer; Christopher A Reid; Meng-Han Tsai
Journal:  Front Neurol       Date:  2022-03-10       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.